Diversifying precision cancer diagnostics and treatments
Company is active
Event Year: 2021
Company is active
Event Year: 2021
Yemaachi Biotechnology is committed to broadening the scope and accessibility of precision cancer diagnostics and treatments. Their approach involves the collection and sequencing of biological samples from across the African continent, a region recognized for its unparalleled genetic diversity. This rich dataset is then leveraged to refine existing diagnostic assays and to facilitate the discovery of novel diagnostic tools by partner organizations. By conducting research activities within Africa, Yemaachi gains unique access to this genetically diverse population, enabling the construction of a pioneering clinical and molecular knowledge base focused on cancer within African populations.
Yemaachi Biotechnology is committed to broadening the scope and accessibility of precision cancer diagnostics and treatments. Their approach involves the collection and sequencing of biological samples from across the African continent, a region recognized for its unparalleled genetic diversity. This rich dataset is then leveraged to refine existing diagnostic assays and to facilitate the discovery of novel diagnostic tools by partner organizations. By conducting research activities within Africa, Yemaachi gains unique access to this genetically diverse population, enabling the construction of a pioneering clinical and molecular knowledge base focused on cancer within African populations.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 16
Hiring: No
Team size: 16
Hiring: No